Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes.
D000328:Adult; D000368:Aged; D001799:Blood Sedimentation; D001827:Body Height; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D010919:Placebos; D011379:Prognosis; D012737:Sex Factors; D013997:Time Factors; D014044:Tolbutamide / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D004071:Digitalis Glycosides; D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol; D014044:Tolbutamide